Skip to main content
Log in

Hepatic intra-arterial infusion of vincristine

  • Original Articles
  • Vincristine, Hepatic Artery Infusion
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Currently the chemotherapeutic agents available for intra-arterial infusion in metastatic liver cancer are limited to only a few. The recent demonstration of the feasibility of prolonged IV infusion of vincristine led to exploration of hepatic intra-arterial infusion of this agent. A continuous infusion of 0.4 mg total dose was administered daily for 5 days via a hepatic artery catheter to each of six patients with metastatic liver cancer. Transient but life-threatening toxicity principally involving the nervous and gastrointestinal systems occurred in five of them. Future investigation of hepatic intra-arterial infusion of vincristine should be based on dose-schedules other than that employed in the current trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jackson DV Jr, Castle MC, Bender RA (1978) Biliary excretion of (3H)-vincristine in man. Clin Pharmacol Ther 24:101–107

    Google Scholar 

  2. Jackson DV Jr, Sethi VS, Spurr CL, Willard V, White DR, Richard F, Stuart JJ, Muss HB, Cooper MR, Homesley HD, Jobson VW, Castle MC (1981a) Intravenous vincristine infusion: Phase I trial. Cancer 48:2559–2564

    Google Scholar 

  3. Jackson DV Jr, Sethi VS, Spurr CL, White DR, Richards F II, Stuart JJ, Muss HB, Cooper MR, Castle MC (1981b) Pharmacokinetics of vincristine intravenous infusion. Cancer Treat Rep 65:1043–1048

    Google Scholar 

  4. Jackson DV Jr, Barringer ML, Sterchi JM, Rosenbaum DL, Sethi VS, Spurr CL (1982) Prolonged biliary excretion of vincristine following intravenous injection. Clin Res 30: 419A

  5. Jackson DV Jr, Barriner ML, Rosenbaum DL, Long TR, Sterchi JM, Meredith W, Sethi VS, Modest EJ, Wells HB, Spurr CL (1983) Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model. Cancer Chemother Pharmacol 10:217–220

    Google Scholar 

  6. Jackson DV Jr, Paschold EH, Spurr CL, Muss HB, Richards F II, Cooper MR, White DR, Stuart JJ, Hopkins JO, Rich R Jr, Wells HB (1984) Treatment of advanced Non-Hodgkin's lymphoma with vincristine infusion. Cancer 53:2601–2606

    Google Scholar 

  7. Lise M, Cagol PP, Nitti D, Feltrin A, Fosser V, Cecchetto A, Rubultelli L, Pucciarelli S (1980) Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver. Int Surg 65:315–323

    Google Scholar 

  8. Sandler SG, Tobin W, Henderson ES (1969) Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 19:367–374

    CAS  PubMed  Google Scholar 

  9. Sethi VS, Burton SS, Jackson DV (1980) A sensitive radioimmunoassay for vincristine and vinblastine. Cancer Chemother Pharmacol 4:183–187

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jackson, D.V., Richards, F., Spurr, C.L. et al. Hepatic intra-arterial infusion of vincristine. Cancer Chemother. Pharmacol. 13, 120–122 (1984). https://doi.org/10.1007/BF00257127

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00257127

Keywords

Navigation